TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 6,216 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
10,500 9,777 7,777 6,532 6,304 6,174 6,263 6,403 6,216
4,588 4,693 2,274 2,119 2,382 2,294 2,515 2,688 2,854
5,912 5,084 5,503 4,413 3,922 3,880 3,748 3,715 3,362
355 365 220 210 443 471 528 469 366
1,929 1,691 1,181 1,158 1,432 1,449 1,684 1,554 1,721
2,640 2,378 1,663 1,566 2,007 2,175 2,421 2,229 2,087
3,272 2,706 3,847 2,847 1,915 1,705 1,327 1,486 1,285
21 45 6.0 6.0 258 422 527 520 504
3,099 2,729 3,696 2,752 1,529 1,122 673 807 425
1,298 576 390 496 178 205 -350 -57 238
1,801 2,153 3,218 2,160 1,351 917 1,023 864 187
5,079 4,379 3,915 2,989 1,982 1,756 1,436 1,604 1,282

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?